Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New Zealand Biotech

This article was originally published in Start Up

Executive Summary

The other land down under is getting serious about moving its affordable world-class science to global markets. For start-ups, establishing a US presence may be key. The three NZ start-ups that we profile in this issue--CoDa Therapeutics, Proacta and Protemix--have found their own paths for taking their technologies to the worldwide market via a US presence.

You may also be interested in...

Protemix Corp. Ltd.

Protemix Corp. Ltd. is leveraging the expertise of its founder, internationally known scientist Garth Cooper, MD, PhD, to discover and develop novel therapies for preventing and treating diabetes and other metabolic disorders and their complications, as well as cardiovascular disease.

CoDa Therapeutics Inc.

CoDa Therapeutics has novel wound care technology that suppresses connexins, the proteins that make up gap junctions. In preclinical studies the company's drugs reduced gap junction formation and communication, as well as inflammation, swelling and scarring, and doubled wound healing rates.

Proacta Inc.

Oncology drug developer Proacta Inc. is taking advantage of tumor hypoxia to activate a nontoxic prodrug to a cytotoxic chemotherapeutic. Since the agent acts only in areas of low oxygenation, it is nontoxic to normal tissues.


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts